Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group

Circulation

Volumn 114, Issue 10, 2006, Pages 1083-1087

  Brosius III, Frank C ^a   Hostetter, Thomas H ^a   Kelepouris, Ellie ^a   Mitsnefes, Mark M ^a   Moe, Sharon M ^a   Moore, Michael A ^a   Pennathur, Subramaniam ^a   Smith, Grace L ^a   Wilson, Peter W F ^a  

^a NONE

Author keywords

AHA Scientific Statements; Albuminuria; Chronic kidney disease; Risk factors

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CYSTATIN C; SERINE PROTEINASE INHIBITOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIET THERAPY; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEALTH PROGRAM; HUMAN; HYPERTENSION; KIDNEY INJURY; MICROALBUMINURIA; PRIORITY JOURNAL; SCREENING TEST;

AMERICAN HOSPITAL ASSOCIATION; CARDIOVASCULAR DISEASES; FOUNDATIONS; KIDNEY DISEASES; RISK FACTORS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33748480111     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.177321     Document Type: Article

References (28)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169.
3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction [published comments in ACP J Club. 2005;142:51, N Engl J Med. 2004;351:1344-1346, and N Engl J Med. 2005;352:199-200; author reply 199-200]. N Engl J Med. 2004;351:1285-1295.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [published comments in ACP J Club. 2005;142:50-51, N Engl J Med. 2004;351:1344-1346, and N Engl J Med. 2005;352:199-200, author reply 199-200]. N Engl J Med. 2004;351:1296-1305.
5. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198-206.
6. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004;44:1343-1353.
7. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, Vera M, Piera C, Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [published comments in Am J Kidney Dis. 2000;36:205-207, Am J Kidney Dis. 2001;37:448-451]. Am J Kidney Dis. 2000;36:29-34.
8. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37:79-83.
9. Hoek FJ, Kemperman FAW, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18:2024-2031.
10. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM, Newman AB, Siscovick D, Shlipak MG; Cardiovascular Health Study. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142:497-505.
11. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement [published comment in Kidney Int. 2005;67:777-778; author reply 778-779]. Kidney Int. 2004;65:1416-1421.
12. Levin A. Cystatin C, serum creatinine, and estimates of kidney function: searching for better measures of kidney function and cardiovascular risk [published comment in Ann Intern Med. 2005;142:497-505]. Ann Intern Med. 2005;142:586-588.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
14. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group [published comments in ACP J Club. 1994;121(suppl 2):46, N Engl J Med. 1994;331:405; author reply 405-406, N Engl J Med. 1994;330:929-930]. N Engl J Med. 1994;330:877-884.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group [published comments in Ann Intern Med. 1999;131:629-630; author reply 630, Ann Intern Med. 2004;140:934; author reply 934-935]. Ann Intern Med. 1999;130:461-470.
16. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, Krumholz HM. Serum urea nitrogen, creatinine, and estimators of renal function mortality in older patients with cardiovascular disease. Arch Intern Med. 2006;166:1134-1142.
17. Levey AS, Greene T, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol. 2000;11:155A.
18. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease [published correction in J Am Soc Nephrol. 2005;16:2814]. J Am Soc Nephrol. 2003;14:2573-2580.
19. Hostetter TH, Lising M. National kidney disease education program. J Am Soc Nephrol. 2003;14:S114-S116.
20. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease [published comments in Ann Intern Med. 2004;141:959-961, Ann Intern Med. 2005;142:679-680; author reply 681]. Ann Intern Med. 2004;141:929-937.
21. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [published comment in J Am Coll Cardiol. 2002;39:1703-1704; author reply 1704-1705]. J Am Coll Cardiol. 2001;38:955-962.
22. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis [published comment in Diabetologia. 1989;32:766-767]. Diabetologia. 1989;32:219-226.
23. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation. 2001;103:1869-1874.
24. American Diabetes Association. Standards of medical care in diabetes [published correction in Diabetes Care. 2005;28:990]. Diabetes Care. 2005;28:S4-S36.
25. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification [published correction in Ann Intern Med. 2003;139:605. Published comments in Ann Intern Med. 2003;139:I36, Ann Intern Med. 2004;140:933-934; author reply 934-935]. Ann Intern Med. 2003;139:137-147.
26. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
27. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(suppl 1):S1-S290.
28. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [published comments in Hypertension. 2004;43:327; author reply e27; Hypertension. 2004;43:1-3; Hypertension. 2004;43:e31; author reply e31]. Hypertension. 2003;42:1206-1252.